Effects of hemoconcentration and sympathetic activation on serum lipid responses to brief mental stress

被引:49
作者
Bachen, EA
Muldoon, MF
Matthews, KA
Manuck, SB
机构
[1] Mills Coll, Dept Psychol, Oakland, CA 94613 USA
[2] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[3] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA
[4] Univ Pittsburgh, Behav Physiol Lab, Pittsburgh, PA USA
来源
PSYCHOSOMATIC MEDICINE | 2002年 / 64卷 / 04期
关键词
cholesterol; lipids; stress; hemoconcentration; sympathetic nervous system;
D O I
10.1097/01.PSY.0000021943.35402.8A
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Previous studies suggest that hemoconcentration may be one mechanism by which acute psychological stress causes elevations of serum total cholesterol and its subfractions. Alternatively, such elevations may result from sympathetically mediated changes in lipid metabolism. This study evaluated these two hypotheses by manipulation of sympathetically mediated responses to stress using a nonselective adrenoceptor antagonist, labetalol. Method: In a 2 x 2 factorial design, 52 healthy male participants were randomly assigned to a stress or no-stress condition and, within each condition, were administered either labetalol or saline. Participants assigned to stress completed three cognitive and evaluative tasks lasting a total of 18 minutes. Indices of hemoconcentration (hematocrit and hemoglobin), heart rate, blood pressure, and serum lipids (total, high-density lipoprotein (HDL), low-density lipoprotein (LDL), free fatty acids, and triglycerides) were assessed at preinfusion and infusion baselines and after mental stress (or rest). Results: Labetalol reduced sympathetic activation, as shown by a substantial reduction in heart rate elevation during stress, but did not alter changes in blood pressure or in hemoconcentration, as indicated by equivalent increases in hematocrit and hemoglobin in the two stressed groups. Labetalol blocked stress-induced increases in free fatty acid concentrations and lowered triglyceride levels but did not influence rises in total, HDL, or LDL cholesterol among stressed subjects. However, arithmetic correction for hemoconcentration eliminated the increases in total, HDL, and LDL cholesterol. Conclusions: These findings suggest that elevations in total cholesterol and its HDL and LDL subfractions during acute stress are caused by accompanying hemoconcentration, whereas concomitant rises in free fatty acids and triglycerides result from the direct metabolic effects of sympathetic activation.
引用
收藏
页码:587 / 594
页数:8
相关论文
共 57 条
[1]   HEMODYNAMIC ADJUSTMENTS TO LABORATORY STRESS - THE INFLUENCE OF GENDER AND PERSONALITY [J].
ALLEN, MT ;
STONEY, CM ;
OWENS, JF ;
MATTHEWS, KA .
PSYCHOSOMATIC MEDICINE, 1993, 55 (06) :505-517
[2]  
ARNER P, 1992, American Journal of Clinical Nutrition, V55, p228S, DOI 10.1093/ajcn/55.1.228s
[3]   PSYCHOLOGICAL PREDICTORS OF NEUROENDOCRINE RESPONSES TO MENTAL STRESS [J].
ARNETZ, BB ;
FJELLNER, B .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 1986, 30 (03) :297-305
[4]   ADRENERGIC-BLOCKADE AMELIORATES CELLULAR IMMUNE-RESPONSES TO MENTAL STRESS IN HUMANS [J].
BACHEN, EA ;
MANUCK, SB ;
COHEN, S ;
MULDOON, MF ;
RAIBLE, R ;
HERBERT, TB ;
RABIN, BS .
PSYCHOSOMATIC MEDICINE, 1995, 57 (04) :366-372
[5]   Free fatty acids and pathogenesis of type 2 diabetes mellitus [J].
Bergman, RN ;
Ader, M .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (09) :351-356
[6]  
Bijlani R L, 1983, Trop Gastroenterol, V4, P168
[7]   PLASMA-LEVEL OF CATECHOLAMINES AND LIPIDS WHEN SPEAKING BEFORE AN AUDIENCE [J].
BOLMAUDORFF, U ;
SCHWAMMLE, J ;
EHLENZ, K ;
KAFFARNIK, H .
WORK AND STRESS, 1989, 3 (03) :249-253
[8]   Peripheral beta-adrenoreceptors and stress-induced hypercholesterolemia in rats [J].
Brennan, FX ;
Cobb, CL ;
Silbert, LH ;
Watkins, LR ;
Maier, SF .
PHYSIOLOGY & BEHAVIOR, 1996, 60 (05) :1307-1310
[9]  
Brindley D. N., 1988, PHOSPHATIDATE PHOSPH, P21
[10]   POSSIBLE CONNECTIONS BETWEEN STRESS, DIABETES, OBESITY, HYPERTENSION AND ALTERED LIPOPROTEIN METABOLISM THAT MAY RESULT IN ATHEROSCLEROSIS [J].
BRINDLEY, DN ;
ROLLAND, Y .
CLINICAL SCIENCE, 1989, 77 (05) :453-461